30 Apr 2021 S 415, narrowing the scope of new chemical entities, is now law: implications for innovator companies By Ellen Scordino, Lisa Haile, Christian Chessman, Jamie Gregorian President Joe Biden has signed into law S 415, amending the Federal Food, Drug, and Cosmetic Act to address the scope of what constitutes...
09 Apr 2021 Life sciences strategies for functional claiming after Amgen By Christian Chessman, Kristin Beale, Stuart E. Pollack